Trademark: 85732632
Status Date
Monday, March 19, 2018
Filing Date
Wednesday, September 19, 2012
Published for Opposition
Tuesday, December 16, 2014
Abandoned Date
Monday, March 19, 2018
5 (Based on Intent to Use) Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives (Based on 44(e) Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives
Color is not claimed as a feature of the mark.
Mar 19, 2018
Abandonment Notice Mailed - No Use Statement Filed
Mar 19, 2018
Abandonment - No Use Statement Filed
Aug 4, 2017
Notice Of Approval Of Extension Request E-Mailed
Aug 3, 2017
Extension 5 Granted
Jul 29, 2017
Extension 5 Filed
Jul 29, 2017
Teas Extension Received
Feb 11, 2017
Notice Of Approval Of Extension Request E-Mailed
Feb 9, 2017
Extension 4 Granted
Feb 9, 2017
Extension 4 Filed
Feb 9, 2017
Teas Extension Received
Aug 13, 2016
Notice Of Approval Of Extension Request E-Mailed
Aug 12, 2016
Extension 3 Granted
Aug 7, 2016
Extension 3 Filed
Aug 7, 2016
Teas Extension Received
Mar 12, 2016
Notice Of Approval Of Extension Request E-Mailed
Mar 11, 2016
Extension 2 Granted
Feb 9, 2016
Extension 2 Filed
Mar 10, 2016
Case Assigned To Intent To Use Paralegal
Feb 9, 2016
Teas Extension Received
Aug 6, 2015
Notice Of Approval Of Extension Request E-Mailed
Aug 4, 2015
Extension 1 Granted
Aug 4, 2015
Extension 1 Filed
Aug 4, 2015
Teas Extension Received
Feb 10, 2015
Noa E-Mailed - Sou Required From Applicant
Dec 16, 2014
Official Gazette Publication Confirmation E-Mailed
Dec 16, 2014
Published For Opposition
Nov 26, 2014
Notification Of Notice Of Publication E-Mailed
Nov 12, 2014
Law Office Publication Review Completed
Nov 3, 2014
Approved For Pub - Principal Register
Oct 27, 2014
Lie Checked Susp - To Atty For Action
Apr 14, 2014
Report Completed Suspension Check Case Still Suspended
Sep 30, 2013
Report Completed Suspension Check Case Still Suspended
Mar 19, 2013
Notification Of Letter Of Suspension E-Mailed
Mar 19, 2013
Letter Of Suspension E-Mailed
Mar 19, 2013
Suspension Letter Written
Mar 14, 2013
Teas/Email Correspondence Entered
Mar 14, 2013
Correspondence Received In Law Office
Mar 6, 2013
Assigned To Lie
Mar 4, 2013
Teas Response To Office Action Received
Feb 5, 2013
Notification Of Non-Final Action E-Mailed
Feb 5, 2013
Non-Final Action E-Mailed
Feb 5, 2013
Non-Final Action Written
Jan 31, 2013
Teas/Email Correspondence Entered
Jan 30, 2013
Correspondence Received In Law Office
Jan 30, 2013
Teas Response To Suspension Inquiry Received
Jan 17, 2013
Notification Of Letter Of Suspension E-Mailed
Jan 17, 2013
Letter Of Suspension E-Mailed
Jan 17, 2013
Suspension Letter Written
Jan 16, 2013
Assigned To Examiner
Sep 22, 2012
New Application Office Supplied Data Entered In Tram
Sep 22, 2012
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
